Johnson & Johnson (JNJ) Joins Hunt for Dengue Fever Drug in Tie-Up With Academia  
8/30/2013 8:40:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson is joining the hunt for drugs to treat dengue fever - the world's fastest-spreading tropical disease - by linking with academic researchers in Belgium and the Wellcome Trust medical charity. There is currently no drug treatment or vaccine for the mosquito-borne viral disease, which is also called "breakbone fever" because of the severe pain it can cause. The tie-up between J&J's Janssen unit and researchers at the University of Leuven, who have received backing from Wellcome, will build on the discovery of a series of chemical compounds that are highly potent in preventing the replication of dengue virus.

Help employers find you! Check out all the jobs and post your resume.